The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Recent advances in leishmaniasis treatment
Open accessAbstract
About 1.5 million new cases of cutaneous leishmaniasis and 500,000 new cases of visceral leishmaniasis occur each year around the world. For over half a century, the clinical forms of the disease have been treated almost exclusively with pentavalent antimonial compounds. In this review, we describe the arsenal available for treating Leishmania infections, as well as recent advances from research on plants and synthetic compounds as source drugs for treating the disease. We also review some new drug-delivery systems for the development of novel chemotherapeutics. We observe that the pharmaceutical industry should employ its modern technologies, which could lead to better use of plants and their extracts, as well as to the development of synthetic and semi-synthetic compounds. New studies have highlighted some biopharmaceutical technologies in the design of the delivery strategy, such as nanoparticles, liposomes, cochleates, and non-specific lipid transfer proteins. These observations serve as a basis to indicate novel routes for the development and design of effective anti-Leishmania drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Leishmaniasis: current situation and new perspectives
Desjeux, P. (2004) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,322
Murray, H. W., Berman, J. D., Davies, C. R., & Saravia, N. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67629-5 · Cited by 1,771
Drug Resistance in Leishmaniasis
Croft, S. L., Sundar, S., & Fairlamb, A. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.111-126.2006 · Cited by 1,663
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández-Pacheco, R., Ibarra, M. R., & Santamaría, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,613
Rates, S. M. K. (2001) · Toxicon · doi:10.1016/s0041-0101(00)00154-9 · Cited by 1,490
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Reithinger, R., Dujardin, J.-C., Louzir, H., Pirmez, C., Alexander, B., & Brooker, S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70209-8 · Cited by 1,334
Synergy research: approaching a new generation of phytopharmaceuticals.
Wagner, H., & Ulrich-Merzenich, G. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.12.018 · Cited by 1,296
Herwaldt, B. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10178-2 · Cited by 1,229
Eloff, J. N. (1998) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(97)00123-2 · Cited by 1,111
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
Croft, S. L., & Coombs, G. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.008 · Cited by 891
Injectable Paromomycin for Visceral Leishmaniasis in India
Sundar, S., Jha, T. K., Thakur, C. P., Sinha, P. K., & Bhattacharya, S. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066536 · Cited by 471
Phlebotomine sand flies and Leishmania parasites: friends or foes?
Kamhawi, S. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.06.012 · Cited by 370
Mikus, J., & Steverding, D. (2000) · Parasitology International · doi:10.1016/s1383-5769(99)00020-3 · Cited by 350
Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil
Braga, F. G., Bouzada, M. L. M., Fabri, R. L., de O. Matos, M., Moreira, F. O., Scio, E., & Coimbra, E. S. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.12.006 · Cited by 305
Natural Products as a Foundation for Drug Discovery
Beutler, J. A. (2009) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0911s46 · Cited by 296
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
DATE, A., JOSHI, M., & PATRAVALE, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.009 · Cited by 293
The interaction index: a measure of drug synergism
Tallarida, R. J. (2002) · Pain · doi:10.1016/s0304-3959(02)00041-6 · Cited by 290
Role of plant lipid transfer proteins in plant cell physiology—A concise review
Carvalho, A. D. O., & Gomes, V. M. (2007) · Peptides · doi:10.1016/j.peptides.2007.03.004 · Cited by 278
Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum
Ueda-Nakamura, T., Mendonça-Filho, R. R., Morgado-Díaz, J. A., Korehisa Maza, P., Prado Dias Filho, B., Aparício Garcia Cortez, D., Alviano, D. S., Rosa, M. D. S. S., Lopes, A. H. C. S., Alviano, C. S., et al. (2006) · Parasitology International · doi:10.1016/j.parint.2005.10.006 · Cited by 247
Self-citationTherapeutic potential of nanoparticulate systems for macrophage targeting
Chellat, F., Merhi, Y., Moreau, A., & Yahia, L. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.044 · Cited by 237
Drug Resistance in Visceral Leishmaniasis
Maltezou, H. C. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/617521 · Cited by 218
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
PEREZVICTORIA, F., SANCHEZCANETE, M., SEIFERT, K., CROFT, S., SUNDAR, S., CASTANYS, S., & GAMARRO, F. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.04.001 · Cited by 211
Life in vacuoles – nutrient acquisition by Leishmania amastigotes
Burchmore, R. J. S., & Barrett, M. P. (2001) · International Journal for Parasitology · doi:10.1016/s0020-7519(01)00259-4 · Cited by 211
Iranshahi, M., Arfa, P., Ramezani, M., Jaafari, M. R., Sadeghian, H., Bassarello, C., Piacente, S., & Pizza, C. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2006.11.002 · Cited by 196
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Antiprotozoal and cytotoxic activities in vitro of Colombian Annonaceae
Osorio, E., Arango, G. J., Jiménez, N., Alzate, F., Ruiz, G., Gutiérrez, D., Paco, M. A., Giménez, A., & Robledo, S. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.01.015 · Cited by 176
Effect of Brazilian copaiba oils on Leishmania amazonensis
Santos, A. O., Ueda-Nakamura, T., Dias Filho, B. P., Veiga Junior, V. F., Pinto, A. C., & Nakamura, C. V. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.08.007 · Cited by 170
Self-citationYardley, V., & Croft, S. L. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00133-8 · Cited by 163
Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis
Santangelo, R., Paderu, P., Delmas, G., Chen, Z.-W., Mannino, R., Zarif, L., & Perlin, D. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2356-2360.2000 · Cited by 150
A PHASE II DOSE-INCREASING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN KENYA
Wasunna, M. K., RASHID, J. R., Mbui, J., Kirigi, G., Kinoti, D., Lodenyo, H. A., Felton, J. M., SABIN, A. J., & HORTON, J. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.871 · Cited by 150
Hepburn, N. C. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00664.x · Cited by 146
Medicinal plants in the fight against leishmaniasis
Iwu, M. M., Jackson, J. E., & Schuster, B. G. (1994) · Parasitology Today · doi:10.1016/0169-4758(94)90398-0 · Cited by 131
Antiprotozoal activity of Brazilian plant extracts from isoquinoline alkaloid-producing families
Tempone, A. G., Borborema, S. E. T., de Andrade, H. F., Gualda, N. C. D. A., Yogi, Á., Carvalho, C. S., Bachiega, D., Lupo, F. N. G., Bonotto, S. V., & Fischer, D. C. H. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.10.007 · Cited by 129
Leishmania spp.: proficiency of drug-resistant parasites
Natera, S., Machuca, C., Padrón-Nieves, M., Romero, A., Díaz, E., & Ponte‐Sucre, A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.01.004 · Cited by 113
Gachet, M. S., Lecaro, J. S., Kaiser, M., Brun, R., Navarrete, H., Muñoz, R. A., Bauer, R., & Schühly, W. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.01.007 · Cited by 112
Evaluation of the leishmanicidal activity of plants used by Peruvian Chayahuita ethnic group
Estevez, Y., Castillo, D., Tangoa, M. P., Arévalo, J., Rojas, R., Castillo, J. A., Deharo, E., Bourdy, G., & Sauvain, M. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.08.007 · Cited by 99
Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids
Weniger, B., Vonthron‐Sénécheau, C., Kaiser, M., Brun, R., & Anton, R. (2005) · Phytomedicine · doi:10.1016/j.phymed.2004.10.008 · Cited by 84
TRIAL OF PNEUMOCOCCAL VACCINE FOR ASPLENIC PATIENTS
Emerson, P. M., Slack, M., Chapel, H., & Mayon-White, R. T. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92420-6 · Cited by 82
Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum
Monzote, L., García, M., Montalvo, A. M., Scull, R., & Martínez, M. M. (2010) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762010000200010 · Cited by 82
Monzote, L., Montalvo, A. M., Scull, R., Martínez, M. M., & Abreu, J. (2007) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652007000400012 · Cited by 78
Fernández-Guerrero, M. L., Robles, P., Rivas, P., Mójer, F., z, G. M. X., & Górgolas, M. (2003) · Acta Tropica · doi:10.1016/j.actatropica.2003.09.009 · Cited by 77
Lakshmi, V., Pandey, K., Kapil, A., Singh, N., Samant, M., & Dube, A. (2005) · Phytomedicine · doi:10.1016/j.phymed.2005.10.002 · Cited by 71
Taşdemir, D., Brun, R., Franzblau, S. G., Sezgin, Y., & Çalış, İ. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.07.032 · Cited by 66
Leishmania amazonensis:Cultivation and Characterization of Axenic Amastigote-like Organisms
Hodgkinson, V. H., Soong, L., Duboise, S. M., & McMahon‐Pratt, D. (1996) · Experimental Parasitology · doi:10.1006/expr.1996.0053 · Cited by 65
Ordóñez‐Gutiérrez, L., Espada, R., Dea‐Ayuela, M. A., Torrado, J. J., Bolás-Fernández, F., & Alunda, J. M. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.013 · Cited by 61
Tomassen, M. M. M., Barrett, D. M., van der Valk, H. C. P. M., & Woltering, E. J. (2007) · Journal of Experimental Botany · doi:10.1093/jxb/erl288 · Cited by 58
Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection
Newens, K. J., Filteau, S., & Tomkins, A. M. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.06.022 · Cited by 53
Synthesis and in vitro activity of limonene derivatives against Leishmania and Trypanosoma
Graebin, C. S., Madeira, M. D. F., Yokoyama-Yasunaka, J. K. U., Miguel, D. C., Uliana, S. R. B., Benítez, D., Cerecetto, H., González, M., da Rosa, R. G., & Eifler-Lima, V. L. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.12.061 · Cited by 52
Potential application of plant lipid transfer proteins for drug delivery
Pato, C., Borgne, M. L., Baut, G. L., Pape, P. L., Marion, D., & Douliez, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00708-0 · Cited by 51
Musonda, C. C., Whitlock, G. A., Witty, M. J., Brun, R., & Kaiser, M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.098 · Cited by 44
Lamidi, M., Giorgio, C. D., Delmas, F., Favel, A., Mve-Mba, C. E., Rondi, M.-L., Ollivier, É., Nze-Ekekang, L., & Balansard, G. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.06.011 · Cited by 44
Aponte, J. C., Vaisberg, A., Castillo, D., González, G., Estevez, Y., Arévalo, J., Quiliano, M., Zimic, M., Verástegui, M., Málaga, E., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.018 · Cited by 42
Al-Qahtani, A. A., Siddiqui, Y. M., Bekhit, A. A., El‐Sayed, O. A., Aboul-Enein, H. Y., & Al‐Ahdal, M. N. (2009) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2009.08.005 · Cited by 20
Cited by
Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities
Chan, W.-K., Tan, L., Chan, K.-G., Lee, L.-H., & Goh, B.-H. (2016) · Molecules · doi:10.3390/molecules21050529 · Cited by 477
Chalcone Derivatives: Promising Starting Points for Drug Design
Gomes, M., Muratov, E., Pereira, M., Peixoto, J., Rosseto, L., Cravo, P., Andrade, C., & Neves, B. (2017) · Molecules · doi:10.3390/molecules22081210 · Cited by 418
Application of Dendrimers for the Treatment of Infectious Diseases
Mhlwatika, Z., & Aderibigbe, B. A. (2018) · Molecules · doi:10.3390/molecules23092205 · Cited by 97
Metadata
- Authors
- Tiuman, T. S., Santos, A. O., Ueda-Nakamura, T., Filho, B. P. D., & Nakamura, C. V.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 15
- Issue
- 8
- Pages
- e525-e532
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2047581463
- Cited by
- 345
- References
- 56
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.